Target intelligence / Profile preview

23S ribosomal RNA of Helicobacter pylori (23S rRNA)

Target
23S rRNA
Molecular classification
Ribosomal RNA, Nucleic acid
01

Overview

The 23S ribosomal RNA (23S rRNA) is a critical structural and functional component of the 50S large ribosomal subunit in Helicobacter pylori (NCBI, 2023). It forms the peptidyl transferase center (PTC), which is responsible for catalyzing the formation of peptide bonds during protein synthesis. This molecule is the primary pharmacological target for macrolide antibiotics, such as clarithromycin, which bind to the V domain of the 23S rRNA to obstruct the nascent peptide exit tunnel (StatPearls, 2023). Inhibition of this process prevents the elongation of polypeptide chains, leading to bacterial stasis or death. Resistance to these drugs frequently arises from specific point mutations in the 23S rRNA gene, notably at positions A2142 and A2143, which reduce drug binding affinity (Megraud, 2004; PubMed). Given H. pylori's role in chronic gastritis, peptic ulcers, and gastric cancer, the 23S rRNA remains a pivotal target for antimicrobial therapy and resistance monitoring.

Other names
23S rRNA50S ribosomal RNAPeptidyl transferase centerrrl gene product
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit and blocking the peptide exit tunnel or interfering with peptidyl transferase activity.

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activity
04

Disease associations

Helicobacter pylori infectionGastritisPeptic ulcer diseaseGastric cancer
05

Safety considerations

Development of antibiotic resistanceCross-resistance within the macrolide classGastrointestinal side effects from treatment
06

Interacting drugs

Clarithromycin

5 more in the full profile.

07

Biomarkers

A2142G mutationA2143G mutationA2142C mutation

Beyond the preview

Go deeper on 23S ribosomal RNA of Helicobacter pylori (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA of Helicobacter pylori (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call